|
RNF115 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.86740001240082E-09 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.23949961405856E-10 |
| Normal-vs-Stage2 |
9.796700E-04 |
| Normal-vs-Stage3 |
3.024400E-02 |
| Normal-vs-Stage4 |
6.899900E-02 |
| Stage1-vs-Stage2 |
1.601970E-01 |
| Stage1-vs-Stage3 |
1.101710E-02 |
| Stage1-vs-Stage4 |
2.150600E-01 |
| Stage2-vs-Stage3 |
4.639800E-01 |
| Stage2-vs-Stage4 |
8.451200E-01 |
| Stage3-vs-Stage4 |
7.070800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.10010001108662E-09 |
| Normal-vs-AfricanAmerican |
1.64674999999503E-05 |
| Normal-vs-Asian |
1.405190E-01 |
| Caucasian-vs-AfricanAmerican |
4.247200E-01 |
| Caucasian-vs-Asian |
9.875200E-01 |
| AfricanAmerican-vs-Asian |
8.141800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.99930097319634E-11 |
| Normal-vs-Female |
2.575500E-03 |
| Male-vs-Female |
3.606500E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
6.214000E-04 |
| Normal-vs-Extreme_Weight |
3.20210524762388E-12 |
| Normal-vs-Obese |
2.49689999999303E-05 |
| Normal-vs-Extreme_Obese |
3.976000E-02 |
| Normal_Weight-vs-Extreme_Weight |
2.861900E-02 |
| Normal_Weight-vs-Obese |
8.720200E-01 |
| Normal_Weight-vs-Extreme_Obese |
8.118000E-01 |
| Extreme_Weight-vs-Obese |
9.616000E-04 |
| Extreme_Weight-vs-Extreme_Obese |
3.618200E-01 |
| Obese-vs-Extreme_Obese |
6.890600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.730300E-02 |
| Normal-vs-Age(41-60Yrs) |
8.71499999943737E-08 |
| Normal-vs-Age(61-80Yrs) |
2.93740032297762E-10 |
| Normal-vs-Age(81-100Yrs) |
6.15459999999679E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.847800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.242960E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.274600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.399170E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.820000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.188600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.62179167265231E-12 |
| Normal-VS-Type2 PRCC |
1.634030E-02 |
| Normal-VS-KIRP CIMP |
3.473400E-01 |
| Normal-VS-Unclassified PRCC |
6.15019999999911E-05 |
| Type1 PRCC-VS-Type2 PRCC |
1.05679999995445E-06 |
| Type1 PRCC-VS-KIRP CIMP |
7.000600E-04 |
| Type1 PRCC-VS-Unclassified PRCC |
3.542000E-03 |
| Type2 PRCC-VS-KIRP CIMP |
6.215600E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
1.079420E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
9.257600E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.67610000048712E-07 |
| Normal-vs-N1 |
4.277800E-01 |
| Normal-vs-N2 |
5.492200E-02 |
| N0-vs-N1 |
4.923000E-03 |
| N0-vs-N2 |
6.218600E-01 |
| N1-vs-N2 |
4.348200E-01 |
|
|
